HTT and Huntington disease: The transgene (derived from a HD patient) expression in these mice is driven by the human HTT promoter and although both lines exhibit HD‐like deficits and pathophysiology, the R6/2 mouse develops disease phenotype most rapidly and a marked accumulation of HTT aggregates in the brain [45, 311].